ArticleExperimental hematology & oncology2026
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer.
Taha Koray Sahin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.